Larvol Delta - Moleculin-Granted-FDA-Fast-Track-Designation-of-WP1122-for-the-Treatment-of-Glioblastoma-Multiforme

WP1122 - Moleculin, CNS Pharma, WPD Pharma

https://www.prnewswire.com/news-releases/moleculin-granted-fda-fast-track-designation-of-wp1122-for-the-treatment-of-glioblastoma-multiforme-301696538.html

Dec 7, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next